• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性心血管因素对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者死亡率的影响。

Effect of selected cardiovascular factors on mortality in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention.

出版信息

Bratisl Lek Listy. 2023;124(6):421-426. doi: 10.4149/BLL_2023_064.

DOI:10.4149/BLL_2023_064
PMID:36876376
Abstract

OBJECTIVE

This work was aimed at analyzing in-hospital, 30-day and 1-year mortality rates, impact of selected cardiovascular factors on mortality of patients with ST-segment elevation myocardial infarction (STEMI) manifested on electrocardiogram (ECG) and treated by the percutaneous coronary intervention (PCI) at our cardiac center, comparing the subgroup of non-shock (survivors and deceased) patients after STEMI and evaluating how these patients differ from each other.

METHODS

In total, 270 patients with STEMI manifested on ECG and treated by PCI were enrolled between April 1, 2018, and March 31, 2019, at our cardiologic center. Our study sought to determine the risk of death after acute myocardial infarction with carefully selected factors and parameters such as the presence of cardiogenic shock, ischemic time, left ventricular ejection fraction (LVEF), post‑PCI TIMI (thrombolysis in myocardial infarction) flow and serum levels of cardio‑specific markers, namely troponin T, creatine kinase and N-terminal pro-brain natriuretic peptide (NT-proBNP). Further evaluation included in-hospital, 30-day and 1-year mortality rates in shock and non-shock patients and determination of factors that influence the survival separately in each subgroup. The follow-up was carried out for 12 months after the myocardial infarction in form of outpatient examinations. After 12 months of follow-up, the collected data were statistically evaluated.

RESULTS

Shock and non-shock patients differed in mortality and several other parameters including NT-proBNP values, ischemic time, TIMI flow defect and LVEF. In all outcomes (in-hospital, 30-day and 1-year mortality rates) the shock patients did worse than non-shock patients (p < 0.001). In addition, age, gender, LVEF, NT-proBNP and post‑PCI TIMI flow less than 3 were found to be important factors influencing the overall survival. In shock patients, the survival was associated with age, LVEF and TIMI flow, while in non-shock patients, the factors predicting survival were age, LVEF, level of NT-proBNP and troponin levels.

CONCLUSION

Shock patients differed in terms of mortality in post-PCI TIMI flow, while non-shock patients varied in troponin and NT-proBNP levels. Despite early intervention, certain risk factors might affect the clinical outcome and prognosis of patients with STEMI treated by PCI (Tab. 5, Fig. 1, Ref. 30). Text in PDF www.elis.sk Keywords: myocardial infarction, primary coronary intervention, shock, mortality, cardio‑specific markers.

摘要

目的

本研究旨在分析我院心血管中心经皮冠状动脉介入治疗(PCI)的心电图(ECG)表现为 ST 段抬高型心肌梗死(STEMI)患者的住院期间、30 天和 1 年死亡率,以及选择的心血管因素对死亡率的影响,并比较 STEMI 后非休克(存活和死亡)患者的亚组,评估这些患者之间的差异。

方法

2018 年 4 月 1 日至 2019 年 3 月 31 日期间,我院心内科共收治 270 例 STEMI 患者行 PCI 治疗。本研究旨在通过仔细选择的因素和参数(如心源性休克、缺血时间、左心室射血分数(LVEF)、PCI 后 TIMI(心肌梗死溶栓)血流和血清心特标志物肌钙蛋白 T、肌酸激酶和 N 端脑钠肽前体(NT-proBNP)水平)确定急性心肌梗死后死亡的风险。进一步评估包括休克和非休克患者的住院期间、30 天和 1 年死亡率,并确定在每个亚组中分别影响生存的因素。通过门诊检查对心肌梗死后 12 个月进行随访。12 个月随访后,对收集的数据进行统计学评估。

结果

休克和非休克患者的死亡率和其他一些参数(包括 NT-proBNP 值、缺血时间、TIMI 血流缺陷和 LVEF)存在差异。在所有结局(住院期间、30 天和 1 年死亡率)中,休克患者的预后均差于非休克患者(p<0.001)。此外,年龄、性别、LVEF、NT-proBNP 和 PCI 后 TIMI 血流<3 被认为是影响总生存率的重要因素。在休克患者中,生存率与年龄、LVEF 和 TIMI 血流相关,而非休克患者中,预测生存率的因素为年龄、LVEF、NT-proBNP 水平和肌钙蛋白水平。

结论

休克患者的 TIMI 血流预后不同,而非休克患者的肌钙蛋白和 NT-proBNP 水平不同。尽管进行了早期干预,但某些危险因素可能会影响 STEMI 患者经 PCI 治疗的临床结局和预后(表 5、图 1、参考文献 30)。

相似文献

1
Effect of selected cardiovascular factors on mortality in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention.选择性心血管因素对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者死亡率的影响。
Bratisl Lek Listy. 2023;124(6):421-426. doi: 10.4149/BLL_2023_064.
2
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].[改良CADILLAC、GRACE和TIMI风险评分对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后短期死亡风险的预测价值比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696.
3
Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.沙库巴曲缬沙坦治疗急性冠脉综合征合并心力衰竭患者的心脏功能改善和心脏重构。
ESC Heart Fail. 2024 Apr;11(2):937-949. doi: 10.1002/ehf2.14646. Epub 2024 Jan 15.
4
[Impact of inflammatory reaction levels and culprit plaque characteristics on preprocedural thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction].[炎症反应水平及罪犯斑块特征对ST段抬高型心肌梗死患者术前溶栓后心肌梗死血流分级的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Feb 24;49(2):150-157. doi: 10.3760/cma.j.cn112148-20200531-00452.
5
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.原代 B 型利钠肽前体 N 端片段浓度与治疗时间及心肌梗死溶栓治疗 (TIMI) 血流的关系:经皮冠状动脉介入治疗评估新治疗策略安全性和有效性的一项亚组研究 (ASSENT IV-PCI 试验)。
Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001.
6
Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中冠状动脉内应用尼可地尔预防无复流现象
Med Sci Monit. 2018 May 4;24:2767-2776. doi: 10.12659/MSM.906815.
7
Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后住院期间主要不良心血管事件风险个体化预测列线图模型的构建与评估
Front Cardiovasc Med. 2022 Dec 21;9:1050785. doi: 10.3389/fcvm.2022.1050785. eCollection 2022.
8
Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.经皮冠状动脉介入治疗的急性ST段抬高型和非ST段抬高型心肌梗死后早期室性心律失常幸存者的长期预后
Am J Cardiol. 2016 Mar 1;117(5):709-13. doi: 10.1016/j.amjcard.2015.12.002. Epub 2015 Dec 13.
9
[Related factors of left ventricular thrombus formation within two weeks in patients with acute ST-segment elevation myocardial infarction and left ventricular aneurysm].[急性ST段抬高型心肌梗死合并左心室室壁瘤患者两周内左心室血栓形成的相关因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Apr 24;49(4):360-367. doi: 10.3760/cma.j.cn112148-20200821-00661.
10
Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.NT-proBNP 在 ACS 患者 PCI 术后心功能正常中的预后价值。
Am J Med Sci. 2022 Apr;363(4):333-341. doi: 10.1016/j.amjms.2021.10.017. Epub 2022 Jan 2.

引用本文的文献

1
Critical appraisal and assessment of bias among studies evaluating risk prediction models for in-hospital and 30-day mortality after percutaneous coronary intervention: a systematic review.系统评价:经皮冠状动脉介入治疗后住院和 30 天死亡率风险预测模型评估的偏倚的评价和评估:一项系统评价。
BMJ Open. 2024 Jul 1;14(6):e085930. doi: 10.1136/bmjopen-2024-085930.